Prism Medico and Pharmacy has closed its trading window for insiders effective April 1. This measure prevents company insiders from buying or selling shares until 48 hours after the financial results for the quarter and financial year ending March 31 are publicly announced. This ensures that all investors have equal access to key financial information before any insider trading can occur.